PRIMARY SYSTEMIC AMYLOIDOSIS

Clinical trials for PRIMARY SYSTEMIC AMYLOIDOSIS explained in plain language.

Never miss a new study

Get alerted when new PRIMARY SYSTEMIC AMYLOIDOSIS trials appear

Sign up with your email to follow new studies for PRIMARY SYSTEMIC AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

Antibody therapy tested for Tough-to-Treat amyloidosis

Disease control Completed

This Phase 2 trial tested whether the antibody drug isatuximab could help control AL amyloidosis in patients whose disease had returned or didn't respond to prior treatments. The study enrolled 43 adults with confirmed organ damage from this rare protein disorder. Participants re…

Matched conditions: PRIMARY SYSTEMIC AMYLOIDOSIS

Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

PRIMARY SYSTEMIC AMYLOIDOSIS

Get alerted when new PRIMARY SYSTEMIC AMYLOIDOSIS trials appear

Antibody therapy tested for Tough-to-Treat amyloidosis